EMEA-001129-PIP01-11-M04

Key facts

Invented name
Plegridy
Active substance
peginterferon beta-1a
Therapeutic area
Neurology
Decision number
P/0371/2019
PIP number
EMEA-001129-PIP01-11-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
  • Subcutaneous use
  • Intramuscular use
Contact for public enquiries
Biogen Idec Ltd

Tel. +44 (0)1628 501014
E-mail: pip.enquiries@biogen.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating